What is the core purpose of the partnership between FMC and Corteva regarding rimisoxafen?

The core purpose of the partnership is to expand the availability of FMC's rimisoxafen herbicide technology across North and South America to address herbicide-resistant weeds in corn and soybean markets.

What financial commitment has Corteva made under the agreement, and what does it secure?

Corteva has made an initial $200 million prepayment for future product supply, securing co-exclusive rights to rimisoxafen under the strategic supply and license agreement with FMC.

FMC and Corteva Partner to Expand Access to Rimisoxafen Technology

Jun 18, 2026

FMC Corporation and Corteva formed a strategic agreement to expand rimisoxafen herbicide technology across the Americas. Corteva made a $200 million prepayment to address resistant weeds in corn and soybeans, with commercial sales expected by the end of the decade.

TradingView

FMC and Corteva Partner to Expand Access to Rimisoxafen Technology

Yahoo Finance Singapore

2026-05-04

Corteva Vylor Spinoff: $9.9 Billion Seed Business Gets a Name Before 2026 Split

2026-06-18

FMC and Corteva Partner to Expand Access to Rimisoxafen Technology

2026-08-21

Albemarle Appoints Max Hood as Chief Accounting Officer with $400,000 Annual Salary

2026-08-21

Albemarle Corporation (ALB) Appoints Max W. Hood as Chief Accounting Officer